Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

871 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human Trypanosoma cruzi chronic infection leads to individual level steady-state parasitemia: Implications for drug-trial optimization in Chagas disease.
De Salazar PM, Sosa-Estani S, Salvador F, Sulleiro E, Sánchez-Montalvá A, Ribeiro I, Molina I, Buckee CO. De Salazar PM, et al. Among authors: ribeiro i. PLoS Negl Trop Dis. 2022 Nov 21;16(11):e0010828. doi: 10.1371/journal.pntd.0010828. eCollection 2022 Nov. PLoS Negl Trop Dis. 2022. PMID: 36409773 Free PMC article.
Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment.
Porrás AI, Yadon ZE, Altcheh J, Britto C, Chaves GC, Flevaud L, Martins-Filho OA, Ribeiro I, Schijman AG, Shikanai-Yasuda MA, Sosa-Estani S, Stobbaerts E, Zicker F. Porrás AI, et al. Among authors: ribeiro i. PLoS Negl Trop Dis. 2015 Jun 4;9(6):e0003697. doi: 10.1371/journal.pntd.0003697. eCollection 2015 Jun. PLoS Negl Trop Dis. 2015. PMID: 26042730 Free PMC article. No abstract available.
Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients.
Ramírez JC, Cura CI, da Cruz Moreira O, Lages-Silva E, Juiz N, Velázquez E, Ramírez JD, Alberti A, Pavia P, Flores-Chávez MD, Muñoz-Calderón A, Pérez-Morales D, Santalla J, Marcos da Matta Guedes P, Peneau J, Marcet P, Padilla C, Cruz-Robles D, Valencia E, Crisante GE, Greif G, Zulantay I, Costales JA, Alvarez-Martínez M, Martínez NE, Villarroel R, Villarroel S, Sánchez Z, Bisio M, Parrado R, Maria da Cunha Galvão L, Jácome da Câmara AC, Espinoza B, Alarcón de Noya B, Puerta C, Riarte A, Diosque P, Sosa-Estani S, Guhl F, Ribeiro I, Aznar C, Britto C, Yadón ZE, Schijman AG. Ramírez JC, et al. Among authors: ribeiro i. J Mol Diagn. 2015 Sep;17(5):605-15. doi: 10.1016/j.jmoldx.2015.04.010. J Mol Diagn. 2015. PMID: 26320872 Free PMC article.
First external quality assurance program for bloodstream Real-Time PCR monitoring of treatment response in clinical trials of Chagas disease.
Ramírez JC, Parrado R, Sulleiro E, de la Barra A, Rodríguez M, Villarroel S, Irazu L, Alonso-Vega C, Alves F, Curto MA, García L, Ortiz L, Torrico F, Gascón J, Flevaud L, Molina I, Ribeiro I, Schijman AG. Ramírez JC, et al. Among authors: ribeiro i. PLoS One. 2017 Nov 27;12(11):e0188550. doi: 10.1371/journal.pone.0188550. eCollection 2017. PLoS One. 2017. PMID: 29176887 Free PMC article.
Implications of asymptomatic infection for the natural history of selected parasitic tropical diseases.
Alvar J, Alves F, Bucheton B, Burrows L, Büscher P, Carrillo E, Felger I, Hübner MP, Moreno J, Pinazo MJ, Ribeiro I, Sosa-Estani S, Specht S, Tarral A, Wourgaft NS, Bilbe G. Alvar J, et al. Among authors: ribeiro i. Semin Immunopathol. 2020 Jun;42(3):231-246. doi: 10.1007/s00281-020-00796-y. Epub 2020 Mar 18. Semin Immunopathol. 2020. PMID: 32189034 Free PMC article. Review.
Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus.
Alonso-Padilla J, Abril M, Alarcón de Noya B, Almeida IC, Angheben A, Araujo Jorge T, Chatelain E, Esteva M, Gascón J, Grijalva MJ, Guhl F, Hasslocher-Moreno AM, López MC, Luquetti A, Noya O, Pinazo MJ, Ramsey JM, Ribeiro I, Ruiz AM, Schijman AG, Sosa-Estani S, Thomas MC, Torrico F, Zrein M, Picado A. Alonso-Padilla J, et al. Among authors: ribeiro i. PLoS Negl Trop Dis. 2020 Apr 23;14(4):e0008035. doi: 10.1371/journal.pntd.0008035. eCollection 2020 Apr. PLoS Negl Trop Dis. 2020. PMID: 32324735 Free PMC article. No abstract available.
Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysis.
Ciapponi A, Barreira F, Perelli L, Bardach A, Gascón J, Molina I, Morillo C, Prado N, Riarte A, Torrico F, Ribeiro I, Villar JC, Sosa-Estani S. Ciapponi A, et al. Among authors: ribeiro i. PLoS Negl Trop Dis. 2020 Aug 17;14(8):e0008529. doi: 10.1371/journal.pntd.0008529. eCollection 2020 Aug. PLoS Negl Trop Dis. 2020. PMID: 32804966 Free PMC article.
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial.
Torrico F, Gascón J, Barreira F, Blum B, Almeida IC, Alonso-Vega C, Barboza T, Bilbe G, Correia E, Garcia W, Ortiz L, Parrado R, Ramirez JC, Ribeiro I, Strub-Wourgaft N, Vaillant M, Sosa-Estani S; BENDITA study group. Torrico F, et al. Among authors: ribeiro i. Lancet Infect Dis. 2021 Aug;21(8):1129-1140. doi: 10.1016/S1473-3099(20)30844-6. Epub 2021 Apr 6. Lancet Infect Dis. 2021. PMID: 33836161 Free article. Clinical Trial.
Serological reactivity against T. cruzi-derived antigens: Evaluation of their suitability for the assessment of response to treatment in chronic Chagas disease.
Alonso-Padilla J, López MC, Esteva M, Zrein M, Casellas A, Gómez I, Granjon E, Méndez S, Benítez C, Ruiz AM, Sanz S, Gascón J, Thomas MC, Pinazo MJ; NHEPACHA Study Group. Alonso-Padilla J, et al. Acta Trop. 2021 Sep;221:105990. doi: 10.1016/j.actatropica.2021.105990. Epub 2021 Jun 6. Acta Trop. 2021. PMID: 34090864 Free article.
871 results